Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$274,800
in 1 filing

Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Charney Laurence N −$275K Director sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Hoberman Kenneth Director Grant or award · Stock Tracking Unit +8,325 8,325
2025-06-12 Hoberman Kenneth Director Grant or award +14,718 279,653
2024-06-19 Hoberman Kenneth Director Grant or award +22,250 264,935
2023-09-28 Hoberman Kenneth Director Grant or award +20,000 242,685
2022-07-20 Hoberman Kenneth Director Grant or award +43,732 222,685
2021-06-18 Hoberman Kenneth Director Grant or award +20,000 178,953
2020-06-22 Hoberman Kenneth Director Grant or award +15,000 158,953
2019-09-17 Hoberman Kenneth Director Grant or award +27,048 143,953
2018-06-26 Hoberman Kenneth Director Grant or award +15,000 116,905
2017-06-16 Hoberman Kenneth Director Grant or award +15,000 101,905
2016-07-06 Hoberman Kenneth Director Grant or award +12,459 86,905
2015-06-04 Hoberman Kenneth Director Grant or award +4,667 74,446

Page 1 of 1 · 12 trades